Abstract
The surgical management of melanoma has evolved over the last several decades based on the published results and long-term follow up of several randomized clinical trials. While management of primary, localized melanoma is generally established, the management of clinically-positive metastasis, recurrent disease or distant melanoma is less clear. Controversies regarding the current surgical management of melanoma remain including the utility of sentinel lymph node biopsy for thin/thick melanoma, the role of completion lymphadenectomy for micrometastatic disease, and the indication for metastectomy for distant disease in the era of targeted therapy, as well as many others. Some of these concerns are being addressed in clinical trials while others remain unanswered. This review addresses these concepts and several others which represent current surgical controversies in the management of melanoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
